Opiant Pharmaceuticals Inc clinical trials
Acquired by Indivior Pharmaceuticals, Inc., Mar 2, 2023 · source ↗
The registry lists 3 studies whose lead sponsor is Opiant Pharmaceuticals Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 14, 2025.
Before and after it joined Indivior Pharmaceuticals, Inc.
- First submitted before Opiant Pharmaceuticals Inc became part of Indivior Pharmaceuticals, Inc.
- 3
- First submitted after Opiant Pharmaceuticals Inc became part of Indivior Pharmaceuticals, Inc.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Opiant Pharmaceuticals Inc3 studies
Something wrong with this grouping? Tell us on the Indivior Pharmaceuticals, Inc. page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Indivior Pharmaceuticals, Inc. studies →
- Pharmacodynamic Evaluation of Intranasal NalmefeneCompletedNCT04828005Phase 1
Sponsor listed in the registry: Opiant Pharmaceuticals Inc · First submitted before Opiant Pharmaceuticals Inc became part of Indivior Pharmaceuticals, Inc.
- Pharmacokinetic Evaluation of Intranasal NalmefeneCompletedNCT04759768Phase 1
Sponsor listed in the registry: Opiant Pharmaceuticals Inc · First submitted before Opiant Pharmaceuticals Inc became part of Indivior Pharmaceuticals, Inc.
- Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing RegimensCompletedNCT05219669Phase 1
Sponsor listed in the registry: Opiant Pharmaceuticals Inc · First submitted before Opiant Pharmaceuticals Inc became part of Indivior Pharmaceuticals, Inc.